EUVIMEDEUVIMED entdecken
Crossref

Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex

Jingxin Chen iD, Ying Zhou, Xueying Wei, Xiaohan Xu, Zhenzhi Qin, Chon Phin Ong, Zi-Wei Ye iD, Dong-Yan Jin iD, Bernard Boitrel iD, Shuofeng Yuan iD, Jasper F-W Chan iD, Hongyan Li und 1 weitere

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.3c00356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Jingxin Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, State Key Laboratory of Synthetic Chemistry and CAS-HKU Joint Laboratory of Metallomics on Health and Environment, The Unive…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Health and Medical Research Fund, Research Grants Council, University Grants Committee, Hong Kong Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19AnimalsViral Nonstructural ProteinsMethyltransferasesS-AdenosylmethionineAntiviral AgentsMammals

Stichwörter der Autor:innen

SARS-CoV-2antiviralbioinorganic chemistrybismuthnsp14 Exon and MTase

Substanzen

Viral Nonstructural ProteinsMethyltransferasesS-AdenosylmethionineAntiviral Agents

Autor:innen und Institutionen

  • Department of Chemistry, State Key Laboratory of Synthetic Chemistry and CAS-HKU Joint Laboratory of Metallomics on Health and Environment, The University of Hong Kong, Pokfulam Road, Pokfulam, Hong Kong 999077, P. R. C…
  • Department of Microbiology, The University of Hong Kong, Sassoon Road, Pokfulam, Hong Kong 999077, P. R. China.
  • School of Biomedical Sciences, The University of Hong Kong, Sassoon Road, Pokfulam, Hong Kong 999077, P. R. China.
  • University of Rennes, CNRS, ISCR (Institut des Sciences Chimiques de Rennes)-UMR 6226, Rennes 35000, France.

ORCID-Profile: Jingxin Chen, Zi-Wei Ye, Dong-Yan Jin, Bernard Boitrel, Shuofeng Yuan, Jasper F-W Chan, Hongzhe Sun

Förderung

  • Health and Medical Research Fund
  • Research Grants Council, University Grants Committee
  • Hong Kong Government
  • National Key Research and Development Program of China
  • University of Hong Kong
  • University Research Committee, University of Hong Kong
  • Innovation and Technology Commission
  • Emergency Key Program of Guangzhou Laboratory

Zitieren

APA

Chen, J., Zhou, Y., Wei, X., Xu, X., Qin, Z., Ong, C. P., Ye, Z. W., Jin, D. Y., Boitrel, B., Yuan, S., Chan, J. F., Li, H., & Sun, H. (2024). Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.3c00356

Vancouver

Chen J, Zhou Y, Wei X, Xu X, Qin Z, Ong CP, et al. Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.3c00356

BibTeX
@article{Chen2024,
  author = {Chen, Jingxin and Zhou, Ying and Wei, Xueying and Xu, Xiaohan and Qin, Zhenzhi and Ong, Chon Phin and Ye, Zi-Wei and Jin, Dong-Yan and Boitrel, Bernard and Yuan, Shuofeng and Chan, Jasper F-W and Li, Hongyan and Sun, Hongzhe},
  title = {Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.3c00356}
}
Kostenlos starten →